Literature DB >> 230051

Metabolic control, glycosylated haemoglobin and high density lipoprotein cholesterol in diabetic children.

L Klujber, D Molnár, M Kardos, V Jászai, G Soltész, J Mestyán.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 230051     DOI： 10.1007/bf00496852

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  33 in total

1.  Studies on the heterogeneity of hemoglobin. V. Binding of hemoglobin with oxidized glutathione.

Authors:  T H HUISMAN; A M DOZY
Journal:  J Lab Clin Med       Date:  1962-08

2.  Hemoglobin AIc as an indicator of the degree of glucose intolerance in diabetes.

Authors:  R J Koenig; C M Peterson; C Kilo; A Cerami; J R Williamson
Journal:  Diabetes       Date:  1976-03       Impact factor: 9.461

3.  [Clinical and biochemical studies on the significance and formation of hemoglobins AIc and AIa+b in diabetes mellitus].

Authors:  R Dolhofer; A Städele; O H Wieland
Journal:  Klin Wochenschr       Date:  1977-10-01

4.  Relation of high-density lipoprotein cholesterol concentration to type of diabetes and its control.

Authors:  A L Kennedy; T R Lappin; T D Lavery; D R Hadden; J A Weaver; D A Montgomery
Journal:  Br Med J       Date:  1978-10-28

5.  Apolipoprotein B levels and altered lipoprotein composition in diabetes.

Authors:  G Schonfeld; C Birge; J P Miller; G Kessler; J Santiago
Journal:  Diabetes       Date:  1974-10       Impact factor: 9.461

6.  A new colorimetric method for determination of serum glucose.

Authors:  M Sugiura; K Hirano
Journal:  Clin Chim Acta       Date:  1977-03-15       Impact factor: 3.786

7.  Glycosylated hemoglobin in normal subjects and subjects with maturity-onset diabetes. Evidence for a saturable system in man.

Authors:  R J Graf; J B Halter; D Porte
Journal:  Diabetes       Date:  1978-08       Impact factor: 9.461

8.  Haemoglobin A1: An indicator of the metabolic control of diabetic patients.

Authors:  B Gonen; A Rubenstein; H Rochman; S P Tanega; D L Horwitz
Journal:  Lancet       Date:  1977-10-08       Impact factor: 79.321

9.  Effects of therapy on plasma-high-density-lipoprotein-cholesterol concentration in diabetes mellitus.

Authors:  G D Calvert; J J Graham; T Mannik; P H Wise; R A Yeates
Journal:  Lancet       Date:  1978-07-08       Impact factor: 79.321

10.  Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus.

Authors:  K H Gabbay; K Hasty; J L Breslow; R C Ellison; H F Bunn; P M Gallop
Journal:  J Clin Endocrinol Metab       Date:  1977-05       Impact factor: 5.958
View more
  7 in total

1.  The metabolic and hormonal effects of continuous subcutaneous insulin infusion therapy in diabetic children.

Authors:  G Soltész; D Molnár; T Decsi; A Hamar; L Klujber
Journal:  Diabetologia       Date:  1988-01       Impact factor: 10.122

2.  Increased high density lipoproteins in diabetic children.

Authors:  U Ewald; S Gustafson; T Tuvemo; B Vessby
Journal:  Eur J Pediatr       Date:  1984-08       Impact factor: 3.183

3.  [Correlations between lipoproteins and glycosylated hemoglobins in juvenile diabetes mellitus (author's transl)].

Authors:  M G Bachem; K Paschen; B Strobel; H U Jastram; E G Janssen; F Dati
Journal:  Klin Wochenschr       Date:  1982-05-17

4.  Serum lipids, microalbuminuria and metabolic control in diabetic children.

Authors:  A Verrotti; F Chiarelli; S Tumini; G Morgese
Journal:  Acta Diabetol Lat       Date:  1991 Jan-Mar

5.  Serum lipids and apolipoproteins in children with type 1 (insulin-dependent) diabetes during the first two years of the disease.

Authors:  M Kobbah; B Vessby; T Tuvemo
Journal:  Diabetologia       Date:  1988-04       Impact factor: 10.122

6.  Paederia foetida Linn. leaf extract: an antihyperlipidemic, antihyperglycaemic and antioxidant activity.

Authors:  Vikas Kumar; Firoz Anwar; Danish Ahmed; Amita Verma; Aftab Ahmed; Zoheir A Damanhouri; Vatsala Mishra; Pramod W Ramteke; Prakash Chandra Bhatt; Mohd Mujeeb
Journal:  BMC Complement Altern Med       Date:  2014-02-25       Impact factor: 3.659

7.  Umbelliferone β-D-galactopyranoside from Aegle marmelos (L.) corr. an ethnomedicinal plant with antidiabetic, antihyperlipidemic and antioxidative activity.

Authors:  Vikas Kumar; Danish Ahmed; Amita Verma; Firoz Anwar; Mohammed Ali; Mohd Mujeeb
Journal:  BMC Complement Altern Med       Date:  2013-10-20       Impact factor: 3.659
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.